Atlanta, GA (PRWEB) September 12, 2012
Now that the healthcare industry has the final mandated ICD-10 conversion date, providers are reinvigorating their ICD-10 programs. This includes revisiting ICD-10 assessment outcomes and conversion plans to determine next steps. However, many of the analytics and priorities established in these plans no longer address business needs. Some are too high-level to be actionable, while others provide little more than theoretical financial anecdotes on ICD-10’s potential revenue impacts. Recognizing this gap, providers are looking for a way to:
During this year’s AHIMA conference (Chicago, IL, September 30 – October 3) Jvion will be on hand to help providers understand how to use the outputs of an ICD-10 financial risk assessment to get conversion plans and activities back on track. The firm will provide demonstrations during exhibit hall hours and one-on-one that will focus on:
Shantanu Nigam, Jvion CEO, commented that, “we are excited to attend this year’s AHIMA conference. With the date now published and a renewed industry focus on ICD-10, we anticipate a lot of attention on how to prioritize conversion efforts, realign existing conversion plans to address revenue risk, and re-engage key stakeholders. October 2014 is not far away and there is plenty to get done to prepare for and address ICD-10’s financial impacts.”
To schedule a personal demonstration of RevCore or to set up a meeting with Jvion during the AHIMA conference, please e-mail allison.alavi(at)jvion(dot)com or visit us at booth #951.
Jvion is a healthcare compliance technology and services organization with a full suite of tools to enable the ICD-10 conversion. The company serves providers and payers in all phases of the ICD-10 conversion process with a simple value proposition—by using Jvion’s tools and solutions, organizations can do more to reduce cost, mitigate risk, and optimize reimbursements with fewer resources and in a shorter time line. Please visit Jvion’s website at http://www.jvion.com for more information.